Literature DB >> 6190921

Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii.

W E Hauser, S D Sharma, J S Remington.   

Abstract

The ability of sonicates of Toxoplasma gondii and of subcellular fractions of the organism to enhance natural killer (NK) cell activity in mice was examined. Treatment of BALB/c mice with the sonicate preparations enhanced peritoneal and splenic NK activity to the level obtained with intact tachyzoites. Similar augmentation of NK activity in A/J, C57BL/6, and C3H/HeJ mice was also observed. Administration of Toxoplasma sonicate intraperitoneally, intravenously, or subcutaneously enhanced both peritoneal and splenic NK activity. Treatment of mice with a sonicate of L929 fibroblast failed to enhance their NK activity. Concentrations of sonicates ranging from 400 to 4 micrograms of protein enhanced both peritoneal and splenic NK activity. Both the soluble and particulate fractions of the sonicate obtained by differential centrifugation were capable of enhancing peritoneal NK activity, whereas splenic NK activity was enhanced only by the particulate fraction. Heat, protease, and sodium periodate treatment of the Toxoplasma sonicate completely abolished its capacity to augment NK activity. Gel filtration studies revealed that the NK augmenting activity of the Toxoplasma sonicate is distributed over a wide molecular weight range.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii.

Authors:  E Grunvald; M Chiaramonte; S Hieny; M Wysocka; G Trinchieri; S N Vogel; R T Gazzinelli; A Sher
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Tiffany M Mundhenke; Jason P Gigley
Journal:  J Immunol       Date:  2019-10-11       Impact factor: 5.422

3.  Intestinal intraepithelial and splenic natural killer cell responses to eimerian infections in inbred chickens.

Authors:  H S Lillehoj
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Diverse roles for T-bet in the effector responses required for resistance to infection.

Authors:  Gretchen Harms Pritchard; Aisling O'Hara Hall; David A Christian; Sagie Wagage; Qun Fang; Gaia Muallem; Beena John; Arielle Glatman Zaretsky; William G Dunn; Jacqueline Perrigoue; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2015-01-02       Impact factor: 5.422

5.  IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Authors:  Sara T Passos; Jonathan S Silver; Aisling C O'Hara; David Sehy; Jason S Stumhofer; Christopher A Hunter
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

6.  Absence of a role for natural killer cells in the control of acute infection by Toxoplasma gondii oocysts.

Authors:  H P Hughes; L H Kasper; J Little; J P Dubey
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Serum protein alterations in dogs naturally infected with Toxoplasma gondii.

Authors:  Gul Fatma Yarim; Cevat Nisbet; Taraneh Oncel; Sena Cenesiz; Gulay Ciftci
Journal:  Parasitol Res       Date:  2007-07-22       Impact factor: 2.289

8.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Authors:  C A Hunter; C S Subauste; V H Van Cleave; J S Remington
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

9.  Antigen-specific lymphocyte transformation induced by oocyst antigens of Eimeria bovis.

Authors:  H P Hughes; K R Thomas; C A Speer
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

10.  Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii.

Authors:  I A Khan; K A Smith; L H Kasper
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.